SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.1600.0%10:08 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FJB who wrote (3261)5/8/2011 3:47:27 PM
From: FJB  Read Replies (1) of 3576
 
First award for embryonic stem cell trial

by Michael Cook | 7 May 2011 |
3:57:49 PM

tags: CIRM, stem cells

The California Institute for Regenerative Medicine (CIRM) has awarded US$25 million to a stem cell company for a clinical trial with embryonic stem cells. This is the first time the $3 billion state agency has funded a clinical trial. The funding for Geron Corp., a California biotechnology company, will be used to support its work on hESCs to treat spinal cord injury.

Chairman Robert Klein described the award as “a landmark step for CIRM”. He framed it as a major test of the credibility of his organisation which was created in 2004 after a referendum which amended the state constitution. “When the people of California voted for proposition 71 they did so with the hope of seeing new therapies for disabling diseases like Alzheimer’s disease, Parkinson’s disease, diabetes and other chronic diseases and injuries. By funding this trial, CIRM is taking a major step toward making that hope a reality.” However, the CIRM may be hedging its bets, as the award is a loan, not a grant.
The use of hESCs to treat recent spinal trauma was the first hESC trial to be cleared by the US Food and Drug Administration. The only other one to date is a treatment for eye disease. ~
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext